Bioxytran Inc - ESG Rating & Company Profile powered by AI
Alternative companies in the scoring peer group for Bioxytran Inc are displayed below. The ESG rating includes seventeen UN SDGs including: 'Zero Hunger', 'Climate Action' and 'Life on Land'. The analysis of Bioxytran Inc incorporates intelligence from across the web and also from public filings by Bioxytran Inc.
Bioxytran Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 8.0, social score of 5.3 and governance score of 5.3.
6.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 427 | Scancell Holdings PLC | 6.3 | High |
| 427 | Verastem Inc | 6.3 | High |
| 450 | Bioxytran Inc | 6.2 | High |
| 450 | Cannasouth Ltd | 6.2 | High |
| 450 | CareDx International AB | 6.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Bioxytran Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Bioxytran Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Bioxytran Inc report the average age of the workforce?
Sign up for free to unlockDoes Bioxytran Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Bioxytran Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Bioxytran Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Bioxytran Inc offer flexible work?
Sign up for free to unlockDoes Bioxytran Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Bioxytran Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Bioxytran Inc conduct supply chain audits?
Sign up for free to unlockDoes Bioxytran Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Bioxytran Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Bioxytran Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Bioxytran Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Bioxytran Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Bioxytran Inc disclose water use targets?
Sign up for free to unlockDoes Bioxytran Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Bioxytran Inc have a product recall in the last two years?
Sign up for free to unlockDoes Bioxytran Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Bioxytran Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Bioxytran Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Bioxytran Inc disclose parental leave metrics?
Sign up for free to unlockDoes Bioxytran Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Bioxytran Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Bioxytran Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Bioxytran Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Bioxytran Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Bioxytran Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Bioxytran Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Bioxytran Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Bioxytran Inc disclose its waste policy?
Sign up for free to unlockDoes Bioxytran Inc report according to TCFD requirements?
Sign up for free to unlockDoes Bioxytran Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Bioxytran Inc disclose energy use targets?
Sign up for free to unlockDoes Bioxytran Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Bioxytran Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Bioxytran Inc
These potential risks are based on the size, segment and geographies of the company.
Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.